{"id":780941,"date":"2023-08-30T09:29:19","date_gmt":"2023-08-30T13:29:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/"},"modified":"2023-08-30T09:29:19","modified_gmt":"2023-08-30T13:29:19","slug":"compass-therapeutics-to-participate-in-upcoming-investor-events","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/","title":{"rendered":"Compass Therapeutics to Participate in Upcoming Investor Events"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BOSTON, Aug.  30, 2023  (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2023.<\/p>\n<p align=\"justify\">\n        <strong>Details are as follows: <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Citi\u2019s 18<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual BioPharma Conference <\/strong><br \/>\n        <br \/>\n        <strong>Location: <\/strong>Boston, MA<br \/><strong>Format: <\/strong>1&#215;1 Meetings<br \/><strong>Date:<\/strong>\u00a0Thursday, September 7<\/p>\n<p align=\"justify\">\n        <strong>H.C. Wainwright 25<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Investment Conference <\/strong><br \/>\n        <br \/>\n        <strong>Location: <\/strong>New York, NY <br \/><strong>Format: <\/strong>Presentation <br \/><strong>Date:<\/strong> Monday, September 11<br \/><strong>Time:<\/strong> 4:00 PM ET <br \/><strong>Webcast Link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j1iHQ4vzfFQe32lurfG-gdFT5GLGGpsNzPHUEI27tUPfM18Haoqn8zdWj_C0AZLtA71kAoz6xKWSQGVaBis-KSYrUilp6aMbz9b7Gel2iVDGWmzXtkAyUIawfsJIsi9giEcd7o3DMIlUmzIU2aAaABYSG-e4gvucnJDl7TR_iGI=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/journey.ct.events<\/a><\/p>\n<p align=\"justify\">\n        <strong>Cantor Fitzgerald Global Healthcare Conference <\/strong><br \/>\n        <br \/>\n        <strong>Location: <\/strong>New York, NY <br \/><strong>Format: <\/strong>Fireside Chat <br \/><strong>Date:<\/strong> Wednesday, September 27<br \/><strong>Time:<\/strong> 2:25-2:55 PM ET <br \/><strong>Webcast Link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j1iHQ4vzfFQe32lurfG-gd-OUI1rpIrmTjp2MBiu9I1j9gOy_zcHH2vQn1roAmv9sgBiyMVZhpNH7DLhNvJE_vfZKJ804T2UrvJpIRb_iN5huHrzB6ZKy3TF02tyL0RMTXqJd_FI43VlIq4oJ6JqIQ==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/cantor19\/cmpx<\/a><\/p>\n<p align=\"justify\">\n        <strong>Virtual\/Replay availability:\u00a0<\/strong>Presentations will be archived for 90 days on Compass\u2019\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7JhYoaWD3Txvr0dNsQQ-hl2RLs3TfEX-y8CU73Us2VRMy0ACOSzAGvXBIw8i-Jb9sTEVZ41bi5ugYP0wnS2nUCAUwNnE1qZf_iEsAol3nZwPkTttON-mfHgTACLqedLczO0QEuVkTQNFXgw6zvlQLFg2EJy6ZvGCRL2jn2Kze7-J9vMXhmIXzTFd-Git6VTCWw8QAAH0O6GzFjUjS1M6iT0pbmHO6nahhcHvPncd7tB3xmoa5m8Ya_az_TV-DPmshD4gqHBKxaVQCA6IUVJB2w==\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a>\u00a0page.<\/p>\n<p>\n        <strong>About Compass Therapeutics<\/strong><br \/>\n        <br \/>Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass\u2019 scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j1iHQ4vzfFQe32lurfG-gcPlX_hlUsSF71p8ZK7oZXNtA8kzOsrmrX8WtAxJd9JfhGWAydrATqF6U_qtLLtQEb71ri-LVeUFnizt-7Sd22im37rkB7px0D4AJSonVeuZqX8NQoBfnxITdbYxa-d2xBcgk_dI6mXiKtExjPJjcTYzB6pRSXKtOSNbWVVufD5i7-0LUlYApjAVbHaWk70-McFBPwVnG744OVNiqBzbAnKQA1RCDLPwKYN1Xc5uBVLtNlqfGjsaMqjm2t-TNjoQLI7KLqlxLczJL0sGmfgMwXXPkA7s9hwSOlSiMOhz4jMclfZMjGSTOt7ak2fcaumrG0J93gVnYDTmjdoYbDtUgIEYfT3HsF3E7crJVGP-SFgbd20lp8VH7Cwi2gdU7urZSIcQo83-yskylov3qhYMKy4UXSoG6dEVkoJL_a7usFXY7WgAev4lpQ-ZpDnEK20Zk_IlYooHJ9NYHngVR6yXtaa7-r0El9BSkf8zkTS6msYp-R__RNMDhLaTQbvSUnsfV0rJ1jDzGoKiXZDpKi4nxJwpIpQWhbMp8jIggsdlKTDJeMJbSbZrfLlFp7n1kON8rZMowvqLV2-Nsya5nvK2xcVC8S0X1i31VWakAhbz9zdyU4m5yP-34Pqhvr48tvW4kCysFOtohsDLHy6B0ET9JKM=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.compasstherapeutics.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JfibLbult8x4EPwVKpzv1mrEEIPnA25FaLzhjGIQoH_5tW4KOLLLxgP19UWEIm1KEOhyVY2ZLnIMydxFImOe7UsxAxDeC7ft-OCL0X5xoMnCPDMc3xPndskqeu812Dg0\" rel=\"nofollow noopener\" target=\"_blank\">ir@compasstherapeutics.com<\/a>\n      <\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Anna Gifford, Communications Manager<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w2Rg7_LkkkfSH1f6uXNWLPbFAzI4JjMgReL64O8hny6NpBCuXa6APGt-vGseUups0O_VYNcHO2BpYNn9duSadsdPOUDGihmp7VHAuJ5HTi10EoQGSpzBA3UDmm8zSTnm\" rel=\"nofollow noopener\" target=\"_blank\">media@compasstherapeutics.com<\/a><br \/>617-500-8099<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzIxNiM1Nzg5NDMxIzIyMDI0MjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MWJhMWJmZjMtNDgwYS00ODQ4LTk5MDEtZmQwMWQwZDI2MTc5LTEyMTM5NzU=\/tiny\/Compass-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2023. Details are as follows: Citi\u2019s 18 th Annual BioPharma Conference Location: Boston, MAFormat: 1&#215;1 MeetingsDate:\u00a0Thursday, September 7 H.C. Wainwright 25 th Annual Global Investment Conference Location: New York, NY Format: Presentation Date: Monday, September 11Time: 4:00 PM ET Webcast Link: https:\/\/journey.ct.events Cantor Fitzgerald Global Healthcare Conference Location: New York, NY Format: Fireside Chat Date: Wednesday, September 27Time: 2:25-2:55 PM ET Webcast Link: https:\/\/wsw.com\/webcast\/cantor19\/cmpx Virtual\/Replay availability:\u00a0Presentations will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Compass Therapeutics to Participate in Upcoming Investor Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-780941","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Compass Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Compass Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2023. Details are as follows: Citi\u2019s 18 th Annual BioPharma Conference Location: Boston, MAFormat: 1&#215;1 MeetingsDate:\u00a0Thursday, September 7 H.C. Wainwright 25 th Annual Global Investment Conference Location: New York, NY Format: Presentation Date: Monday, September 11Time: 4:00 PM ET Webcast Link: https:\/\/journey.ct.events Cantor Fitzgerald Global Healthcare Conference Location: New York, NY Format: Fireside Chat Date: Wednesday, September 27Time: 2:25-2:55 PM ET Webcast Link: https:\/\/wsw.com\/webcast\/cantor19\/cmpx Virtual\/Replay availability:\u00a0Presentations will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics &hellip; Continue reading &quot;Compass Therapeutics to Participate in Upcoming Investor Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-30T13:29:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzIxNiM1Nzg5NDMxIzIyMDI0MjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Compass Therapeutics to Participate in Upcoming Investor Events\",\"datePublished\":\"2023-08-30T13:29:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzIxNiM1Nzg5NDMxIzIyMDI0MjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/\",\"name\":\"Compass Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzIxNiM1Nzg5NDMxIzIyMDI0MjI=\",\"datePublished\":\"2023-08-30T13:29:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzIxNiM1Nzg5NDMxIzIyMDI0MjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzIxNiM1Nzg5NDMxIzIyMDI0MjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Compass Therapeutics to Participate in Upcoming Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Compass Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"Compass Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk","og_description":"BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2023. Details are as follows: Citi\u2019s 18 th Annual BioPharma Conference Location: Boston, MAFormat: 1&#215;1 MeetingsDate:\u00a0Thursday, September 7 H.C. Wainwright 25 th Annual Global Investment Conference Location: New York, NY Format: Presentation Date: Monday, September 11Time: 4:00 PM ET Webcast Link: https:\/\/journey.ct.events Cantor Fitzgerald Global Healthcare Conference Location: New York, NY Format: Fireside Chat Date: Wednesday, September 27Time: 2:25-2:55 PM ET Webcast Link: https:\/\/wsw.com\/webcast\/cantor19\/cmpx Virtual\/Replay availability:\u00a0Presentations will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics &hellip; Continue reading \"Compass Therapeutics to Participate in Upcoming Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-30T13:29:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzIxNiM1Nzg5NDMxIzIyMDI0MjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Compass Therapeutics to Participate in Upcoming Investor Events","datePublished":"2023-08-30T13:29:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzIxNiM1Nzg5NDMxIzIyMDI0MjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/","name":"Compass Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzIxNiM1Nzg5NDMxIzIyMDI0MjI=","datePublished":"2023-08-30T13:29:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzIxNiM1Nzg5NDMxIzIyMDI0MjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzIxNiM1Nzg5NDMxIzIyMDI0MjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Compass Therapeutics to Participate in Upcoming Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780941","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=780941"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780941\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=780941"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=780941"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=780941"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}